Researchers have created and characterized a novel, three-component cross-coupling reaction that is a 'tremendous leap forward' in developing effective and practical iron-based reactions that could be used to create pharmaceuticals. Unlike palladium, the transition metal catalyst most often used in industry and academic labs, iron is abundant, cheap and relatively nontoxic.
source https://www.sciencedaily.com/releases/2021/10/211025101711.htm
0 comments: